Letermovir 240 mg, 480 mg, 100 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Tablet / Injection
Available Strengths: 240 mg, 480 mg, 100 mg/mL
Reference Brands: Prevymis (USA/EU)
Category: Anti Viral
Letermovir is a Anti Viral product available as Tablet / Injection in strengths 240 mg, 480 mg, 100 mg/mL. It corresponds to the reference brand Prevymis (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Letermovir, marketed under the brand name Prevymis, is an antiviral medication used for the prevention and treatment of cytomegalovirus (CMV) infections. It is primarily indicated in adult patients undergoing allogeneic stem cell transplantation, where CMV infection can pose a significant risk. Letermovir works by selectively inhibiting the CMV DNA terminase complex, a key enzyme essential for viral replication, thereby preventing the virus from multiplying and spreading.
Beyond stem cell transplant patients, lettermovir shows potential benefits for other immunocompromised populations, including individuals with organ transplants or HIV infections, where CMV can lead to serious complications. The drug was initially developed by Bayer’s anti-infective division, later continued by AiCuris Anti-infective Cures AG through early clinical development, and subsequently acquired by Merck & Co. for Phase 3 trials and regulatory approval.
Available in both oral tablets and intravenous formulations, lettermovir provides flexible administration options tailored to patient needs. Its targeted mechanism and favorable safety profile make it a valuable therapy in the management of CMV infections, contributing to improved outcomes in patients with compromised immune systems and reducing the risk of CMV-related morbidity and mortality.
Letermovir — third party manufacturing & bulk supply
Letermovir 240 mg, 480 mg, 100 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Letermovir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Letermovir →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Letermovir is used to prevent cytomegalovirus (CMV) infection and disease in adults undergoing allogeneic stem cell transplantation.
It is a selective antiviral that inhibits the CMV DNA terminase complex, blocking viral replication.
The trade name is Prevymis.
Letermovir is marketed by Merck & Co. (MSD).
The generic name is letermovir.
The brand name is Prevymis.
Letermovir is manufactured in USA, EU, and UK facilities under approved pharmaceutical standards.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
